The Top 5 Questions to Ask When Developing a REMS
![Close up photo of IV drip on a blurred background](https://ubc.com/wp-content/uploads/2020/09/5-Questions-Developing-REMS-1275x1080-1-1024x867.png)
A REMS should be considered when risk mitigation efforts are required beyond product labeling and routine pharmacovigilance.
The Essential Role of Real World Evidence Combating COVID-19
![Tablet with KPI metrics, graphs, charts and heatmaps popping out of it as a blurred figure analyzes the data.](https://ubc.com/wp-content/uploads/2020/06/RWE-for-COVID-1275x1080-1-1024x867.png)
Are you prepared for potential accelerated approval requirements?
ISPE’s Position on Real World Evidence (RWE)
![Business man looking at a tablet on the table and thinking as he studies the charts and graphs popping out of the screen.](https://ubc.com/wp-content/uploads/2020/03/ISPE-Position-on-RWE-1275x1080-1-1024x867.png)
Read more about the February 2020 position on RWE from ISPE.
Lack of Label Alignment & Patient Safety Implications
![Closeup action photo of an unknown female pushing a syringe into a held vial without a label.](https://ubc.com/wp-content/uploads/2020/02/Lack-of-Label-Alignment-1275x1080-1-1024x867.png)
Read the full article from UBC’s pharmacovigilance team in Drugs Real World Outcomes.
Risk Management Plan Development & Implementation
![Close up of podcast microphone with two unknown people facing the mic and a computer with audio wavelengths in the background.](https://ubc.com/wp-content/uploads/2019/12/REMS-Development-Implementation-1275x1080-1-1024x867.png)
Listen to the full podcast from UBC with PharmaVOICE here.
Are You Ready For Sentinel? | New RWE Safety Initiative
![Team of diverse business people looking at a computer and discussing analytics with an imprint of the data overlaying the photo including lots of text and graphs. Data and analytics concept.](https://ubc.com/wp-content/uploads/2019/10/Are-You-Ready-for-Sentinel-1275x1080-1-1024x867.png)
With continued investment in the RWE space, find out how to meet the needs of regulators, payers, and prescribers.
Immunogenicity: Meeting the Safety Reporting Requirements
![Close up photo of computer monitor showing all kinds of data analytics, metrics, graphs, charts, trendlines. Metrics dashboard.](https://ubc.com/wp-content/uploads/2019/09/Immunogenecity-Safety-Reporting-1275x1080-1-1024x867.png)
Discover why it is imperative to assess the potential of therapeutic proteins throughout the product lifecycle.
DIA 2019: Watch the Wrap-up of UBC’s Participation
![UBC Tradeshow booth showing signage, several presentation screens, private meeting booth and branded tables.](https://ubc.com/wp-content/uploads/2019/07/DIA-2019-Blog-1275x1080-1-1024x867.png)
See more of the developments UBC’s evidence development and safety & risk management teams discussed.
UBC Presents Observational & Investigational Studies
![Technology concept showing two women analyzing and pointing to data insights on a computer that is overlaid on the image in a holograph.](https://ubc.com/wp-content/uploads/2019/04/Observational-vs-Investigational-1275x1080-1-1024x867.png)
Watch Chief Scientific Officer Dr. Annette Stemhagen discuss in this video.
Clinical Trial Trends – OCT West Coast Conference Wrap-Up
![Technology concept photo showing three colleagues talking in the background and data being overlaid on them with biometrics, charts, graphs, reports and insights.](https://ubc.com/wp-content/uploads/2019/02/OCT-West-Coast-2019-1275x1080-1-1024x867.png)
Read the latest in the world of clinical trials out of this industry event.